Tag Archive for: astraveus

Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell FactoryTM for CAR-T therapy manufacturing

/in

Agreement with Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen) for the manufacturing of CAR-T therapies using Lakhesys Benchtop Cell FactoryTM Partnership to demonstrate the ability of Astraveus’ technology to deliver reduced costs and increased efficiency in CAR-T manufacturing Paris, France, 6 May 2025 – Astraveus SAS (“Astraveus” or the […]

Read more

Astraveus Strengthens Leadership Team and Board

/in

Jean-Paul Mangeolle joins as Chairman of the Board of Directors David Newble appointed as an Independent Board Member Laurence Riot Lamotte appointed as Chief Financial Officer New hires reflect continuing progress at Astraveus as Company prepares for launch of the Lakhesys Benchtop Cell FactoryTM Paris, France, 15 April 2025 – Astraveus SAS (“Astraveus” or the […]

Read more

Astraveus opens path to accessible cell therapies with first ever end-to-end microfluidic CAR-T production

/in

Paris, France, 9 January 2025 – Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces the first ever successful end-to-end production of CAR-T cells within a microfluidic benchtop system. Using its fully automated Lakhesys Benchtop Cell FactoryTM, Astraveus has been able to demonstrate the potential of its unique microfluidic cell therapy processing […]

Read more

Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus

/in

Paris, France, 28 November, 2023 – Astraveus SAS (“Astraveus” or the “Company”), the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT) manufacturing, today announces the appointment of Michel Spagnol as its new Chairman of the Board. Michel joins existing Board members Jérémie Laurent, CEO; Alain Huriez, Director; AdBio Partners; Christian […]

Read more

Astraveus awarded €10.4 million grant by the French government as part of France 2030 investment plan

/in

Significant endorsement by the French government programme that promotes excellence in research and manufacturing of novel biotherapies Advances the Company’s ambitions for its Lakhesys™ platform Total company funding now over €30 Million Paris, France, October 24, 2023 – Astraveus SAS (“Astraveus” or the “Company”), the creator of modular, microfluidic cell foundries that transform cell and […]

Read more